Although these TRM-like signatures described in the literature present overlap with classical TRM CD4 T cells in healthy tissues, it is still difficult to make the distinction between tissue residency and chronic activation, especially during cancer, autoimmunity, and virus immune response42,43,47,48. This evidence concerns the gene CD4 and cancer.